Walking Tall Health's vision is to help 10 million people living with Parkinson’s disease walk. We are seeking $800k ($600k already committed/indicated) to launch onBeat2 in 12 months and are flexible to investor needs. Endorsed by early adopters, onBeat2 is the first medical device with clinical trials evidence to improve mobility and prevent falls. Our goal is to secure first-mover advantage in Australian ($672M TAM) then globally ($8.4B TAM).